US 10940133
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted A61KA61K31/27A61K31/325
Quick answer
US patent 10940133 (Methods of providing solriamfetol therapy to subjects with impaired renal function) held by Jazz Pharmaceuticals Ireland Limited expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals Ireland Limited
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/27, A61K31/325, A61K9/0053, A61P